Cyclic pyranopterin monophosphate
From Infogalactic: the planetary knowledge core
| 250px | |
| Names | |
|---|---|
| Other names
cPMP; Precursor Z
|
|
| Identifiers | |
150829-29-1  |
|
| Jmol 3D model | Interactive image |
| PubChem | 25202908 |
|
|
| Properties | |
| C10H14N5O8P | |
| Molar mass | 363.22 g·mol−1 |
| Vapor pressure | {{{value}}} |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
 verify (what is  ?) |
|
| Infobox references | |
Cyclic pyranopterin monophosphate (cPMP) is an experimental treatment for molybdenum cofactor deficiency type A, which was developed by José Santamaría-Araujo and Guenter Schwarz at the German universities TU Braunschweig and the University of Cologne.[1][2]
cPMP is a precursor to molybdenum cofactor, which is required for the enzyme activity of sulfite oxidase, xanthine dehydrogenase/oxidase and aldehyde oxidase.[3]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Doctors risk untried drug to stop baby’s brain dissolving, TimesOnline, November 5, 2009
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- Guenter Schwarz Laboratory, Institute for Biochemistry - University of Cologne (English, German)
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
